论文信息 - Inhibition of SNI-2011 Metabolism by CYP2D6 and 3A4 Inhibitors - 字舞流文

Inhibition of SNI-2011 Metabolism by CYP2D6 and 3A4 Inhibitors

T. Kawashiro | K. Yamashita | M. Niwa | Kyoko Shiiya

[1] K. Kohsaka,et al. Identification of human drug-metabolizing enzymes involved in the metabolism of SNI-2011. , 2001, Biological & pharmaceutical bulletin.

[2] Y. Iga,et al. (+/-)-cis-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine] hydrochloride, hemihydrate (SNI-2011, cevimeline hydrochloride) induces saliva and tear secretions in rats and mice: the role of muscarinic acetylcholine receptors. , 1998, Japanese journal of pharmacology.

[3] T. Tomizuka,et al. Long-lasting salivation induced by a novel muscarinic receptor agonist SNI-2011 in rats and dogs. , 1997, European journal of pharmacology.

[4] B. W. Penman,et al. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450. , 1997, Analytical biochemistry.

[5] T. Masuhara,et al. Sialogogic activities of SNI-2011 compared with those of pilocarpine and McN-A-343 in rat salivary glands: identification of a potential therapeutic agent for treatment of Sjörgen's syndrome. , 1994, General pharmacology.